Around menopause, antipsychotic effectiveness in women decreases and psychosis relapse risk increases. Researchers found that estrogen-boosting menopausal hormone therapy was associated with a 16% decreased risk of psychosis relapse in women beginning therapy between 40-55, but not after.
This might have been posted previously.